Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication
Safety Tips Always consult with a healthcare professional before considering peptide therapy
This helps ensure that B12 is considered in the context of the whole diet, other vitamins, and any coexisting medical conditions
Product Specifications Laboratory Handling Store the dry solid at -20C, sealed and protected from light and moisture
.jpg)